BioCentury | Dec 8, 2003
Company News

Pharmagene management update

...Openshaw as EVP for corporate development, formerly executive director in the Life Sciences Group at WestLB Panmure...
BioCentury | Nov 11, 2003
Financial News

New bank in London

...Capital. Code will be led by Chief Executive Chris Collins, who formerly was head of WestLB Panmure's...
BioCentury | Oct 27, 2003
Finance

Ebb & Flow

...the European biotech sector from the firm's London office. He previously covered European biotech for WestLB Panmure...
BioCentury | Oct 22, 2003
Financial News

Jefferies hires Campbell to sellside team

...a senior equity research analyst covering European biotech companies. Campbell previously covered European biotech for WestLB Panmure...
BioCentury | Apr 7, 2003
Company News

ReNeuron Ltd., Merlin BioSciences deal

...Feb. 28, 2003, REN had £5.7 million ($9 million) in cash. REN was advised by WestLB Panmure...
BioCentury | Apr 1, 2003
Company News

Merlin to acquire ReNeuron

...As of Feb. 28, 2003, REN had L5.7 million in cash. REN was advised by WestLB Panmure...
BioCentury | Apr 15, 2002
Finance

Ebb & Flow

...dressing device to treat leg ulcers. Nomura will be the joint broker on the deal. WestLB Panmure...
BioCentury | Apr 8, 2002
Top Story

Ark announces IPO plans

...graft surgery in hemodialysis patients and EG009 in Phase IIb trials to treat malignant glioma. WestLB Panmure...
BioCentury | Apr 8, 2002
Finance

Ebb & Flow

...blood vessel blockage after vascular graft surgery in hemodialysis patients, and two Phase II compounds. WestLB Panmure...
BioCentury | Feb 11, 2002
Finance

Ebb & Flow

...BioCentury, Nov. 12, 2001). "The coffers are expected to run dry by year end," said WestLB Panmure...
...£327 million ($463 million). Vaccine play Bavarian Nordic (CSE:BAVA) fell DKK17 (20%) to DKK67 after WestLB Panmure...
Items per page:
1 - 10 of 32
BioCentury | Dec 8, 2003
Company News

Pharmagene management update

...Openshaw as EVP for corporate development, formerly executive director in the Life Sciences Group at WestLB Panmure...
BioCentury | Nov 11, 2003
Financial News

New bank in London

...Capital. Code will be led by Chief Executive Chris Collins, who formerly was head of WestLB Panmure's...
BioCentury | Oct 27, 2003
Finance

Ebb & Flow

...the European biotech sector from the firm's London office. He previously covered European biotech for WestLB Panmure...
BioCentury | Oct 22, 2003
Financial News

Jefferies hires Campbell to sellside team

...a senior equity research analyst covering European biotech companies. Campbell previously covered European biotech for WestLB Panmure...
BioCentury | Apr 7, 2003
Company News

ReNeuron Ltd., Merlin BioSciences deal

...Feb. 28, 2003, REN had £5.7 million ($9 million) in cash. REN was advised by WestLB Panmure...
BioCentury | Apr 1, 2003
Company News

Merlin to acquire ReNeuron

...As of Feb. 28, 2003, REN had L5.7 million in cash. REN was advised by WestLB Panmure...
BioCentury | Apr 15, 2002
Finance

Ebb & Flow

...dressing device to treat leg ulcers. Nomura will be the joint broker on the deal. WestLB Panmure...
BioCentury | Apr 8, 2002
Top Story

Ark announces IPO plans

...graft surgery in hemodialysis patients and EG009 in Phase IIb trials to treat malignant glioma. WestLB Panmure...
BioCentury | Apr 8, 2002
Finance

Ebb & Flow

...blood vessel blockage after vascular graft surgery in hemodialysis patients, and two Phase II compounds. WestLB Panmure...
BioCentury | Feb 11, 2002
Finance

Ebb & Flow

...BioCentury, Nov. 12, 2001). "The coffers are expected to run dry by year end," said WestLB Panmure...
...£327 million ($463 million). Vaccine play Bavarian Nordic (CSE:BAVA) fell DKK17 (20%) to DKK67 after WestLB Panmure...
Items per page:
1 - 10 of 32